These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6029674)

  • 1. [Hormone excretion during and after treatment with Lyndiol 2.5].
    Keller M
    Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
    Moses LE; Goldzieher JW; Moses IG
    Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of various oral contraceptives on hormone secretion of the hypophysis and ovary in the sexually mature female].
    Schmidt-Elmendorff H; Kaiser E
    Arch Gynakol; 1971 Jun; 211(1):233-4. PubMed ID: 5108862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ovulation inhibitors and ACTH reserve].
    Rindt W; Heinen G; Oertel GW
    Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of lynestrenol (Lyndiol) as an oral contraceptive agent.
    Connell EB; Stone ML
    J Am Med Womens Assoc; 1967 Dec; 22(12):951-5. PubMed ID: 4230214
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Report on practical experiences with Lyndiol and Lyndiol 2.5].
    Falus M
    Med Welt; 1967 Dec; 50():3089-92. PubMed ID: 5610831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Change in calcium metabolism in women during prolonged treatment with 2,5 mg of Lyndiol].
    Chef R
    Bull Soc R Belge Gynecol Obstet; 1967; 37(4):255-63. PubMed ID: 5619668
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action duration of lynestrenol as a component of an anticontraceptive agent].
    Schmidt-Elmendorff H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):352-5. PubMed ID: 5148892
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol".
    Farbiszewski R; Kurowska T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
    Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prolonged feeding of an ovulation inhibitor (Lyndiol) on ageing of the hypothalamic-ovarian axis and pituitary gland tumorigenesis in rats.
    Zeilmaker GH
    J Endocrinol; 1969 Jan; 43(1):xxi-xxii. PubMed ID: 5815247
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptives and follicle-stimulating hormone.
    Schmidt-Elmendorff H; Kopera H
    Lancet; 1968 Jun; 1(7553):1194-5. PubMed ID: 4172299
    [No Abstract]   [Full Text] [Related]  

  • 17. The levels of free and conjugated 17-hydroxycorticosteroids (17-OHCS) in theplasma of users of oral contraceptives.
    Pekkarinen A; Ulkkinen MO
    Ann Chir Gynaecol Fenn; 1969; 58(2):105-11. PubMed ID: 5363956
    [No Abstract]   [Full Text] [Related]  

  • 18. A new oral contraceptive with a 7 plus 15 sequential formulation.
    Brosens I; Van Assche A; Wijnants P
    Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Personal experiences with Anacyclin].
    Vrobel T; Kovác R; Kovácová L
    Cesk Gynekol; 1973 May; 38(4):234-5. PubMed ID: 4717896
    [No Abstract]   [Full Text] [Related]  

  • 20. Return of ovulation after discontinuance of oral contraceptives.
    Rice-Wray E; Correu S; Gorodovsky J; Esquivel J; Goldzieher JW
    Fertil Steril; 1967; 18(2):212-8. PubMed ID: 6020669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.